Nextgen Biomed Balance Sheet Health
Financial Health criteria checks 4/6
Nextgen Biomed has a total shareholder equity of ₪10.2M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪12.8M and ₪2.7M respectively.
Key information
0%
Debt to equity ratio
₪0
Debt
| Interest coverage ratio | n/a |
| Cash | ₪2.34m |
| Equity | ₪10.16m |
| Total liabilities | ₪2.66m |
| Total assets | ₪12.82m |
Financial Position Analysis
Short Term Liabilities: NXGN's short term assets (₪2.7M) exceed its short term liabilities (₪1.3M).
Long Term Liabilities: NXGN's short term assets (₪2.7M) exceed its long term liabilities (₪1.3M).
Debt to Equity History and Analysis
Debt Level: NXGN is debt free.
Reducing Debt: NXGN had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if NXGN has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NXGN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.